Q3 2021 Holdings
Filed 2021-11-15 | 82 holdings | $22.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.7M | 677,900 | 24.9% |
| Cerus Corp(CERS) | COM | 157085101 | $3.8M | 619,369 | 16.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.1M | 173,327 | 13.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $3.1M | 37,249 | 13.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.1M | 38,243 | 9.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.8M | 49,309 | 7.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.2M | 4,389 | 5.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.0M | 49,382 | 4.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $511.0K | 42,022 | 2.2% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $297.0K | 6,208 | 1.3% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $211.0K | 5,000 | 0.9% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $8.6K | 61,897 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $8.3K | 179,548 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.1K | 45,941 | 0.0% |
| Merus N V | COM | N5749R100 | $7.6K | 345,964 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $6.2K | 516,221 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $5.7K | 52,469 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.7K | 437,866 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $5.2K | 185,691 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $4.9K | 721,302 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.8K | 174,588 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $4.7K | 473,396 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.9K | 21,189 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.8K | 101,890 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.7K | 649,919 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $3.6K | 163,486 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $3.3K | 57,704 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $3.2K | 116,931 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $2.5K | 620,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.4K | 60,170 | 0.0% |
| Chemocentryx Inc(CCXIEUR)Put | COM | 16383L106 | $2.4K | 139,200 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $2.2K | 365,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.2K | 223,906 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $2.1K | 1,259,840 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $2.0K | 388,632 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $2.0K | 11,749 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $2.0K | 93,122 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.0K | 1,017,048 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.9K | 707,733 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $1.9K | 274,833 | 0.0% |
| Benitec Biopharma Inc(BNTC1EUR) | COM | 08205P100 | $1.8K | 498,009 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.7K | 106,078 | 0.0% |
| Lucira Health Inc | COM | 54948U105 | $1.7K | 220,758 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.6K | 23,855 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.6K | 291,696 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.6K | 208,559 | 0.0% |
| Compugen LTD(CGEN)Call | ORD | M25722105 | $1.5K | 248,000 | 0.0% |
| Polypid LTD | SHS | M8001Q118 | $1.4K | 183,230 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.4K | 288,042 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.3K | 129,290 | 0.0% |